Clinical Trial

Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy

Study acronym: STEMJOINT
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This phase I and II double blinded randomized clinical controlled trial investigates the safety and efficacy of intraarticular knee injection with allogenic adipose derived mesenchymal stem cells (AD-MSC), in patients suffering from mild-moderate knee osteoarthritis compared to placebo injection with saline.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-26; most recent amendment 2024-06-08.
Status change: Not Yet Recruiting → Recruiting 2024-06-08
Trial Details
NCT Number NCT05933434
Lead Sponsor Aarhus University Hospital
Conditions Knee Osteoarthritis
Enrollment 80 participants
Start Date 2024-03-07
Primary Completion 2030-10 (estimated)
Study Completion 2030-10 (estimated)
Updated on ClinicalTrials.gov 2024-06-11